Published on 21/05/2019 5:28:43 PM | Source: Dion Global Solutions Ltd

Eris Lifesciences Q4 net profit down 8.83% at Rs 52.42 cr

Now Get news on WhatsAppClick Here To Know More

The company reported standalone net profit of Rs 52.42 crore for the quarter ended March 31, 2019 as compared to Rs 57.50 crore in the same period last year, registering a year-on-year decline of 8.83 per cent. Net revenue of the company rose by 0.28 per cent at Rs 194.61 crore in January-March quarter of this fiscal as against Rs 194.07 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 11.98 per cent to Rs 136.51 crore from Rs 121.91 crore in year ago period.

Other Income grew by 41.46 per cent at Rs 11.60 crore versus (Mar'18 Rs 8.20 crore). Operating Profit slipped by 14.20 per cent to Rs 61.92 crore as against Rs 72.17 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 14.42 per cent in March quarter. Interest declined by 43.26 per cent y-o-y to Rs 4.38 crore, while Taxation decreased by 9.35 per cent at Rs 6.69 crore (Mar'18 Rs 7.38 crore).